American Century Companies’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VKTX
American Century Companies's VKTX Position: Q2 2026 in Review
American Century Companies reduced its Viking Therapeutics (VKTX) stake by 13% in Q2 2026, selling an estimated $8.48M and leaving 1,816,050 shares worth $70.8M. The position accounts for 0.03% of the portfolio, ranked #683.
American Century Companies first reported a position in VKTX in Q3 2018 and has held it in 21 quarters since. 436 funds tracked by Wall St. Rank hold VKTX as of Q2 2026.
- American Century Companies held 1,816,050 shares of Viking Therapeutics worth $70.8M as of Q2 2026.
- American Century Companies sold 262,527 Viking Therapeutics shares in Q2 2026, an estimated $8.48M.
- Viking Therapeutics made up 0.03% of American Century Companies's portfolio in Q2 2026, its #683 holding.
- American Century Companies first reported a position in Viking Therapeutics in Q3 2018 and has held it in 21 quarters since.
- 436 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2026.
Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.